MOUNTAIN VIEW, Calif., Feb. 22 PharsightCorporation (Nasdaq: PHST), a leading provider of software, strategicconsulting, and regulatory services for optimizing clinical drug developmentannounced today that it will be presenting at Jesup and Lamont's 2008 EmergingGrowth Stock Conference on February 28, 2008 at the Walt Disney Contemporaryresort in Orlando, FL. Shawn O'Connor, Pharsight's President and CEO, andWilliam Frederick, Senior Vice President and CFO, will present the company'sbusiness strategy and financial results on February 28, 2008, at 8:15 a.m.Eastern Standard Time (5:15 a.m. PST).
Attendance at the conference is by invitation only. A live webcast of thepresentation will be broadcast via the Internet. Those interested inlistening to the webcast may access it at Jesup and Lamont's website athttp://www.jesuplamontconferences.com. You must first register to have accessto the webcast.
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products andservices that enable pharmaceutical and biotechnology companies to achievesignificant and enduring improvements in the development and use oftherapeutic products. Pharsight's goal is to help customers reduce the time,cost and risk of drug development, as well as optimize the post-approvalmarketing and use of pharmaceutical products.
Pharsight's approach enhances the fundamental element of drug developmentsuccess: strong decision-making. By adopting the Pharsight approach, customersacquire a new decision-making process with the potential to systematicallyimprove every level and phase of their business and scientific processes.Pharsight Corporation is headquartered in Mountain View, California.Information about Pharsight is available at http://www.pharsight.com
SOURCE Pharsight Corporation